Shareholding29 Aug 2026, 05:10 pm
Swapan Khandelwal Acquires 0.81% Stake in Goldline Pharma
AI Summary
Goldline Pharmaceutical Ltd announced that Mr. Swapan Khandelwal, a Promoter and Whole Time Director, acquired 78,000 equity shares representing 0.81% of the total issued and paid-up share capital. The acquisition occurred on August 28, 2026, through open market purchases. Following this transaction, Mr. Khandelwal's total holding in the company increased to 2,809,988 shares, representing 29.27% of the total issued and paid-up share capital. The disclosure was made under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Key Highlights
- Promoter acquired 78,000 shares, increasing stake by 0.81%.
- Total promoter holding now stands at 29.27%.
- Acquisition was made through open market purchases.
- Disclosure filed under SEBI SAST Regulations, 2011.
Price Impact
More from GLPL